إعلان
إعلان
PRME
Prime Medicine, Inc. Common Stock
3.93
USDبرعاية
+0.01
+0.23%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
3.97
+0.04
+1.04%
تقارير أرباح PRME
النسبة الإيجابية المفاجئة
PRME تفوق 3 من 12 آخر التقديرات.
25%
التقرير التالي
بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.35M
/-$0.25
التغير الضمني من Q3 25 (Revenue/ EPS)
+92.11%
/-21.88%
التغير الضمني من Q4 24 (Revenue/ EPS)
+7.80%
/-19.35%
Prime Medicine, Inc. Common Stock earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, PRME reported earnings of -0.32 USD per share (EPS) for Q3 25, missing the estimate of -0.25 USD, resulting in a -23.98% surprise. Revenue reached 1.23 مليون, compared to an expected 1.05 مليون, with a 17.04% difference. The market reacted with a -8.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 المحللين forecast an EPS of -0.25 USD, with revenue projected to reach 2.35 مليون USD, implying an نقصان of -21.88% EPS, and زيادة of 92.11% in Revenue from the last quarter.
الأسئلة الشائعة
What were Prime Medicine, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Prime Medicine, Inc. Common Stock reported EPS of -$0.32, missing estimates by -23.98%, and revenue of $1.23M, 17.04% above expectations.
How did the market react to Prime Medicine, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -8.85%, changed from $4.18 before the earnings release to $3.81 the day after.
When is Prime Medicine, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
What are the forecasts for Prime Medicine, Inc. Common Stock's next earnings report?
Based on 14
المحللين, Prime Medicine, Inc. Common Stock is expected to report EPS of -$0.25 and revenue of $2.35M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان